ATLASATLAS fair value
₹1,537
Below fair value · 28% discount
Range: ₹1,383–₹1,691Fair valuePrice
Eris Lifesciences (ERIS.NSE)
Eris Lifesciences share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
₹1,105▲ +0.89%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Eris Lifesciences in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Eris Lifesciences
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Eris Lifesciences's fair value at about ₹1,537 per share (reasonable range: ₹1,383 to ₹1,691). At ₹1,105, the stock trades 28% below it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Eris Lifesciences a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹1,065 and ₹1,155; in 9 out of 10, between ₹990.90 and ₹1,241. Estimated annual volatility is 21%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹155B
- Market cap (USD)
- $1.6B
- P/E ratio
- 23.2
- Dividend yield
- 1.32%
- 52-week high
- ₹1,740
- 52-week low
- ₹1,069
- Revenue (12 months)
- ₹32.1B
- Operating margin
- 25.8%
- Net margin
- 20.0%
- Beta
- -0.03
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Eris Lifesciences sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks ERIS.NSE has traded between ₹1,069 and ₹1,740. Today it is 36.5% below that high and 3% above its low.
On the business: net margin is 20.0%; it trades at 23.2 times earnings.
Its beta is -0.03: it tends to move less than the market.
About the company
Eris Lifesciences Ltd. is a prominent pharmaceutical company engaged in the development, manufacturing, and distribution of a wide array of pharmaceutical products.
Want to see everything about Eris Lifesciences?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Eris Lifesciences (ERIS.NSE) fair value?
About ₹1,537 per share according to ATLAS (reasonable range: ₹1,383 to ₹1,691). With the stock at ₹1,105, it is 28% below it.
What is the chance ERIS.NSE goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, ERIS.NSE ends the month between ₹1,065 and ₹1,155.
How big is Eris Lifesciences and what is its P/E ratio?
Eris Lifesciences's market capitalization is ₹155B. Its price-to-earnings (P/E) ratio is 23.2: you pay ₹23.2 for each ₹1.00 of yearly earnings.
Does Eris Lifesciences pay a dividend?
Yes. ERIS.NSE's current dividend yield is 1.32% at today's price (₹1,105).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer